Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy

Molecular Endocrinology

Volumn 22, Issue 11, 2008, Pages 2532-2543

  Kim, Jaetaek ^a,c   Wende, Adam R ^a   Sena, Sandra ^a   Theobald, Heather A ^a   Soto, Jamie ^a   Sloan, Crystal ^a   Wayment, Benjamin E ^b   Litwin, Sheldon E ^b   Holzenberger, Martin ^d   LeRoith, Derek ^e   Abel, E Dale ^a,f  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Chung Ang University   (South Korea)

^d INSERM   (France)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f Program in Human Molecular Biology and Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; DRUG DERIVATIVE; ELONGATION FACTOR 2; RIBONUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXERCISE; GLYCOGEN ANALYSIS; HEART DEVELOPMENT; HEART SIZE; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SWIMMING; ANIMAL; BIOLOGICAL MODEL; CARDIOMEGALY; CELL CULTURE; CELL ENLARGEMENT; CYTOLOGY; DRUG EFFECT; GENETICS; HEART CONTRACTION; HEART MUSCLE CELL; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

EUKARYOTA; MUS; RATTUS;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CARDIOMEGALY; CELL ENLARGEMENT; CELLS, CULTURED; MALE; MICE; MICE, KNOCKOUT; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PEPTIDE ELONGATION FACTOR 2; PHYSICAL EXERTION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; RIBONUCLEOTIDES; SIGNAL TRANSDUCTION; SWIMMING;

EID: 55049090844     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0265     Document Type: Article

References (42)

1. Heineke J, Molkentin JD 2006 Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589-600
2. Dorn 2nd GW 2007 The fuzzy logic of physiological cardiac hypertrophy. Hypertension 49:962-970
3. Shiojima I, Walsh K 2006 Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev 20:3347-3365
4. Debosch B, Sambandam N, Weinheimer C, Courtois M, Muslin AJ 2006 Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem 281:32841-32851
5. DeBosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M, Muslin AJ 2006 Akt1 is required for physiological cardiac growth. Circulation 113:2097-2104
6. Luo J, McMullen JR, Sobkiw CL, Zhang L, Dorfman AL, Sherwood MC, Logsdon MN, Horner JW, DePinho RA, Izumo S, Cantley LC 2005 Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol Cell Biol 25:9491-9502
7. McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Kang PM, Izumo S 2003 Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci USA 100:12355-12360
8. Scheinowitz M, Kessler-Icekson G, Freimann S, Zimmermann R, Schaper W, Golomb E, Savion N, Eldar M 2003 Short- and long-term swimming exercise training increases myocardial insulin-like growth factor-I gene expression. Growth Horm IGF Res 13:19-25
9. Neri Serneri GG, Boddi M, Modesti PA, Cecioni I, Coppo M, Padeletti L, Michelucci A, Colella A, Galanti G 2001 Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res 89:977-982
10. Delaughter MC, Taffet GE, Fiorotto ML, Entman ML, Schwartz RJ 1999 Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice. FASEB J 13:1923-1929
11. McMullen JR, Shioi T, Huang WY, Zhang L, Tarnavski O, Bisping E, Schinke M, Kong S, Sherwood MC, Brown J, Riggi L, Kang PM, Izumo S 2004 The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110α) pathway. J Biol Chem 279:4782-4793
12. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, Abel ED 2002 Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 109:629-639
13. Sena S, Rasmussen IR, Wende AR, McQueen AP, Theobald HA, Wilde N, Pereira RO, Litwin SE, Berger JP, Abel ED 2007 Cardiac hypertrophy caused by peroxisome proliferator-activated receptor-γ agonist treatment occurs independently of changes in myocardial insulin signaling. Endocrinology 148:6047-6053
14. Shiojima I, Yefremashvili M, Luo Z, Kureishi Y, Takahashi A, Tao J, Rosenzweig A, Kahn CR, Abel ED, Walsh K 2002 Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J Biol Chem 277:37670-37677
15. Yin Z, Jones GN, Towns 2nd WH, Zhang X, Abel ED, Binkley PF, Jarjoura D, Kirschner LS 2008 Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis. Circulation 117:1414-1422
16. Knudtson KL, Boes M, Sandra A, Dake BL, Booth BA, Bar RS 2001 Distribution of chimeric IGF binding protein (IGFBP)-3 and IGFBP-4 in the rat heart: importance of C-terminal basic region. Endocrinology 142:3749-3755
17. O'Neill B T, Kim J, Wende AR, Theobald HA, Tuinei J, Buchanan J, Guo A, Zaha VG, Davis DK, Schell JC, Boudina S, Wayment B, Litwin SE, Shioi T, Izumo S, Birnbaum MJ, Abel ED 2007 A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. Cell Metab 6:294-306
18. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, Izumo S 2000 The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19:2537-2548
19. Dyck JR, Lopaschuk GD 2006 AMPK alterations in cardiac physiology and pathology: enemy or ally? J Physiol 574:95-112
20. Chan AY, Soltys CL, Young ME, Proud CG, Dyck JR 2004 Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J Biol Chem 279:32771-32779
21. Wende AR, Schaeffer PJ, Parker GJ, Zechner C, Han DH, Chen MM, Hancock CR, Lehman JJ, Huss JM, McClain DA, Holloszy JO, Kelly DP 2007 A role for the transcriptional coactivator PGC-1α in muscle refueling. J Biol Chem 282:36642-36651
22. Daitoku H, Yamagata K, Matsuzaki H, Hatta M, Fukamizu A 2003 Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 52:642-649
23. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, Spiegelman B, Montminy M 2001 CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413:179-183
24. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD 2000 The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19:6341-6350
25. Fujioka D, Kawabata K, Saito Y, Kobayashi T, Nakamura T, Kodama Y, Takano H, Obata JE, Kitta Y, Umetani K, Kugiyama K 2006 Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am J Physiol Heart Circ Physiol 290:H2409-H2416
26. Browne GJ, Finn SG, Proud CG 2004 Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J Biol Chem 279:12220-12231
27. Coven DL, Hu X, Cong L, Bergeron R, Shulman GI, Hardie DG, Young LH 2003 Physiologic role of AMP-activated protein kinase (AMPK) in the heart: graded activation during exercise. Am J Physiol Endocrinol Metab 285:E629-E636
28. Czubryt MP, McAnally J, Fishman GI, Olson EN 2003 Regulation of peroxisome proliferator-activated receptor gamma coactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5. Proc Natl Acad Sci USA 100:1711-1716
29. Schaeffer PJ, Wende AR, Magee CJ, Neilson JR, Leone TC, Chen F, Kelly DP 2004 Calcineurin and calcium/calmodulin-dependent protein kinase activate distinct metabolic gene regulatory programs in cardiac muscle. J Biol Chem 279:39593-39603
30. Wright DC, Geiger PC, Han DH, Jones TE, Holloszy JO 2007 Calcium induces increases in peroxisome proliferator-activated receptor γ coactivator-1α and mitochondrial biogenesis by a pathway leading to p38 mitogen-activated protein kinase activation. J Biol Chem 282:18793-18799
31. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME 2001 Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21:952-965
32. Musaro A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N 1999 IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400:581-585
33. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ 2004 The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14:395-403
34. Dehoux M, Gobier C, Lause P, Bertrand L, Ketelslegers JM, Thissen JP 2007 IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3β pathways and inhibition of atrogin-1 mRNA. Am J Physiol Endocrinol Metab 292:E145-E150
35. White MF 2006 Regulating insulin signaling and β-cell function through IRS proteins. Can J Physiol Pharmacol 84:725-737
36. Cadoret A, Desbois-Mouthon C, Wendum D, Leneuve P, Perret C, Tronche F, Housset C, Holzenberger M 2005 c-myc-induced hepatocarcinogenesis in the absence of IGF-I receptor. Int J Cancer 114:668-672
37. Desbois-Mouthon C, Wendum D, Cadoret A, Rey C, Leneuve P, Blaise A, Housset C, Tronche F, Le Bouc Y, Holzenberger M 2006 Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout. FASEB J 20:773-775
38. Abel ED, Kaulbach HC, Tian R, Hopkins JC, Duffy J, Doetschman T, Minnemann T, Boers ME, Hadro E, Oberste-Berghaus C, Quist W, Lowell BB, Ingwall JS, Kahn BB 1999 Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest 104:1703-1714
39. McMullen JR, Amirahmadi F, Woodcock EA, Schinke-Braun M, Bouwman RD, Hewitt KA, Mollica JP, Zhang L, Zhang Y, Shioi T, Buerger A, Izumo S, Jay PY, Jennings GL 2007 Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 104:612-617
40. Kaplan ML, Cheslow Y, Vikstrom K, Malhotra A, Geenen DL, Nakouzi A, Leinwand LA, Buttrick PM 1994 Cardiac adaptations to chronic exercise in mice. Am J Physiol 267:H1167-H1173
41. Frank DU, Fotheringham LK, Brewer JA, Muglia LJ, Tristani-Firouzi M, Capecchi MR, Moon AM 2002 An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development 129:4591-4603
42. Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, Abel ED 2007 Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56:2457-2466